Vilin Bio Med Ltd.

As of March 31, 2025, Vilin Bio Med Ltd. carries a market capitalization of 284.58M, placing it among publicly traded companies globally. Its enterprise value stands at 309.75M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2025, Vilin Bio Med Ltd. has 13.95M shares outstanding.

These figures are as of March 31, 2025.

As of March 31, 2025, Vilin Bio Med Ltd. maintains a current ratio of 2.75, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Vilin Bio Med Ltd.'s stock has gained approximately 88.70% over the past 52 weeks. The 50-day moving average sits at 50.39, while the 200-day moving average is 38.66.

As of March 31, 2025, Vilin Bio Med Ltd. holds 561,000.00 in cash and equivalents against 25.73M in total debt, resulting in a net debt position of 25.17M. Total book value stands at 230.64M, with working capital of 79.91M providing operational flexibility.